Serum uric acid levels correlate with left ventricular ejection fraction and systolic pulmonary artery pressure in patients with heart failure;I livelli sierici di acido urico correlano con la frazione di eiezione del ventricolo sinistro e con la pressione arteriosa polmonare sistolica in pazienti con scompenso cardiaco

Recenti Progressi in Medicina

Volumn 98, Issue 12, 2007, Pages 619-623

  Pinelli, Massimiliano ^a   Bindi, Massimo ^a,b   Filardo, Francesca Paola ^a   Moroni, Federica ^a   Castiglioni, Maido ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b NONE   (Italy)

Author keywords

Heart failure; Left ventricular ejection fraction; Systolic pulmonary artery pressure; Uric acid

Indexed keywords

URIC ACID;

AGED; ARTICLE; CORRELATION ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERURICEMIA; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

AGED; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PULMONARY ARTERY; REGRESSION ANALYSIS; STROKE VOLUME; URIC ACID; VENTRICULAR FUNCTION, LEFT;

EID: 38549163276     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bakhtiiarov ZA. Changes in xanthine oxidase activity in patients with circulatory failure [in Russian]. Ter Arkh 1989; 61: 68-9.
2. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997; 18: 858-65.
3. Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats JS. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart 1997; 78: 39-43.
4. Doehner W, Rauchhaus M, Florea VG, Sharma R, Bolger AP, Davos CH, et al. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance. Am Heart J 2001; 141: 792-9.
5. Wajner M, Harkness RA. Distribution of xanthine dehydrogenase and oxidase activities in human and rabbit tissues. Biochim Biophys Acta 1988; 991: 79-84.
6. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 104: 2407-11.
7. Kittleson MM, Hare JM. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure. Eur Heart J 2005; 26: 1458-60.
8. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 2001; 104:2996-3007.
9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
10. Doehner W, Anker SD. Uric acid in chronic heart failure. Semin Nephrol 2005; 24: 61-6.
11. Hassoun PM, Shedd A, Lanzillo J, Thappa V, Landman M, Fanburg B. Inhibition of pulmonary artery smooth muscle cell growth by hypoxanthine, xanthine and uric acid. Am J Respir Cell Mol Biol 1992; 6: 617-24.
12. Terada LS, Guidot DM, Leff JA, Willingham IR, Hanley ME, Piermattei D, et al. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 1992; 89: 3362-6.
13. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure. Circulation 2002; 106: 3073-8.
14. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997;100: 2153-7.
15. Recchia FA, McConnell PI, Bernstein RD. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998; 83: 969-79.
16. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 1996; 943: 1223-9.
17. Perez NG, Gao WD, Marban E. Novel myofilament Ca2+ sensitizing property of xanthine oxidase inhibitors. Circ Res 1998; 83: 423-30.
18. Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 1999; 85: 437-45.
19. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure. Circulation 2003; 107: 1991-7.
20. Nagaya N, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Nakanishi N, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 1999; 160: 487-92.
21. Voelkel MA, Wynne KM, Badesch DB, Groves BM, Voelkel NF. Hyperuricemia in severe pulmonary hypertension. Chest 2000; 117: 19-24.
22. Car N, Skrabala Z, Verha M. The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. Curr Med Res Opin 1988; 11: 133-41.
23. Thomas RD, Newill A, Morgan DB. The cause of the raised plasma urea of acute heart failure. Postgrad Med J 1979; 55: 10-4.0